• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周血单个核细胞中与免疫相关的 microRNA 表达模式在多发性硬化症的复发和缓解中存在差异。

Immune-related miRNA expression patterns in peripheral blood mononuclear cells differ in multiple sclerosis relapse and remission.

机构信息

Pirogov Russian National Research Medical University, Moscow 117997, Russia; National Medical Research Center for Cardiology, Moscow 121552, Russia.

Pirogov Russian National Research Medical University, Moscow 117997, Russia; National Medical Research Center for Cardiology, Moscow 121552, Russia.

出版信息

J Neuroimmunol. 2018 Apr 15;317:67-76. doi: 10.1016/j.jneuroim.2018.01.005. Epub 2018 Jan 5.

DOI:10.1016/j.jneuroim.2018.01.005
PMID:29325906
Abstract

MiRNAs were shown to participate in development of autoimmune inflammatory process in multiple sclerosis (MS). To investigate miRNAs involvement in relapse-remission MS course, we analyzed expression of immune-related miRNAs in PBMC of treatment-naïve relapsing and remitting MS patients and healthy controls. The upregulation of miR-126-3p, miR-146b-5p, miR-155, miR-196a-5p, miR-21-5p, miR-223-3p, miR-326 and miR-379-5p in remission compared to relapse was observed; when apply gender stratification, miR-223-3p and miR-379-5p were upregulated only in men. Therefore, miRNAs play essential role in maintaining stable MS course and this process has certain gender-specific differences.

摘要

miRNAs 被证明参与了多发性硬化症(MS)自身免疫炎症过程的发展。为了研究 miRNAs 在复发缓解型 MS 病程中的参与,我们分析了未经治疗的复发缓解型 MS 患者和健康对照者 PBMC 中免疫相关 miRNAs 的表达。与复发相比,我们观察到 miR-126-3p、miR-146b-5p、miR-155、miR-196a-5p、miR-21-5p、miR-223-3p、miR-326 和 miR-379-5p 在缓解期的上调;当进行性别分层时,仅在男性中观察到 miR-223-3p 和 miR-379-5p 的上调。因此,miRNAs 在维持稳定的 MS 病程中发挥着重要作用,而这一过程具有一定的性别特异性差异。

相似文献

1
Immune-related miRNA expression patterns in peripheral blood mononuclear cells differ in multiple sclerosis relapse and remission.外周血单个核细胞中与免疫相关的 microRNA 表达模式在多发性硬化症的复发和缓解中存在差异。
J Neuroimmunol. 2018 Apr 15;317:67-76. doi: 10.1016/j.jneuroim.2018.01.005. Epub 2018 Jan 5.
2
CSF microRNAs discriminate MS activity and share similarity to other neuroinflammatory disorders.脑脊液 microRNAs 可区分 MS 活动,并与其他神经炎症性疾病具有相似性。
Neurol Neuroimmunol Neuroinflamm. 2020 Feb 7;7(2). doi: 10.1212/NXI.0000000000000673. Print 2020 Mar 5.
3
miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study.miR-132-3p、miR-106b-5p 和 miR-19b-3p 与脑源性神经营养因子的产生及多发性硬化的临床活动相关:一项初步研究。
Genet Test Mol Biomarkers. 2021 Nov;25(11):720-726. doi: 10.1089/gtmb.2021.0183.
4
Differential microRNA expression in blood in multiple sclerosis.多发性硬化症患者血液中的差异 microRNA 表达。
Mult Scler. 2013 Dec;19(14):1849-57. doi: 10.1177/1352458513490542. Epub 2013 Jun 17.
5
Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.醋酸格拉替雷治疗可使复发缓解型多发性硬化症中失调的 microRNA 表达正常化。
PLoS One. 2011;6(9):e24604. doi: 10.1371/journal.pone.0024604. Epub 2011 Sep 16.
6
Exosomal microRNA signatures in multiple sclerosis reflect disease status.多发性硬化症中的外泌体 microRNA 特征反映了疾病状态。
Sci Rep. 2017 Oct 30;7(1):14293. doi: 10.1038/s41598-017-14301-3.
7
Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis.全球外泌体转录组谱分析揭示多发性硬化症的生物标志物。
Ann Neurol. 2017 May;81(5):703-717. doi: 10.1002/ana.24931.
8
Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.复发缓解型多发性硬化症患者外周血单个核细胞中miR-125a-5p和miR-218-5p的下调
Immunol Invest. 2022 Jul;51(5):1149-1161. doi: 10.1080/08820139.2021.1909616. Epub 2021 Apr 19.
9
Micro-RNA 18b and interleukin 17A profiles in relapsing remitting multiple sclerosis.微小 RNA 18b 和白细胞介素 17A 在复发缓解型多发性硬化症中的特征。
Mult Scler Relat Disord. 2019 Feb;28:226-229. doi: 10.1016/j.msard.2018.12.013. Epub 2018 Dec 14.
10
Analysis of potential microRNA biomarkers for multiple sclerosis.多发性硬化症潜在 microRNA 标志物分析。
Exp Mol Pathol. 2024 Jun;137:104903. doi: 10.1016/j.yexmp.2024.104903. Epub 2024 May 20.

引用本文的文献

1
Short-term exposure to particulate matter triggers a selective alteration of plasma extracellular vesicle-packaged miRNAs in a mouse model of multiple sclerosis.在多发性硬化症小鼠模型中,短期暴露于颗粒物会引发血浆细胞外囊泡包裹的微小RNA的选择性改变。
Front Immunol. 2025 Jul 3;16:1596935. doi: 10.3389/fimmu.2025.1596935. eCollection 2025.
2
Cladribine tablets in the new multiple sclerosis era.新多发性硬化症时代的克拉屈滨片
Ther Adv Neurol Disord. 2025 Jun 19;18:17562864251342855. doi: 10.1177/17562864251342855. eCollection 2025.
3
Exosomal microRNAs as Early Transition Biomarkers from Recurrent-Remissive to Secondary Progressive Multiple Sclerosis.
外泌体微小RNA作为复发缓解型多发性硬化向继发进展型多发性硬化早期转变的生物标志物
Int J Mol Sci. 2025 Apr 20;26(8):3889. doi: 10.3390/ijms26083889.
4
Identification of RN7SK LncRNA as a novel biomarker in Alzheimer's disease using bioinformatics and expression analysis.利用生物信息学和表达分析鉴定RN7SK长链非编码RNA作为阿尔茨海默病的新型生物标志物
Sci Rep. 2024 Dec 28;14(1):31192. doi: 10.1038/s41598-024-82490-9.
5
Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis.微小 RNA 表达与血清神经丝轻链水平与多发性硬化症的临床和放射学表现的关联。
Int J Mol Sci. 2024 Sep 17;25(18):10012. doi: 10.3390/ijms251810012.
6
Stem Cell-Derived Exosomal MicroRNAs as Novel Potential Approach for Multiple Sclerosis Treatment.干细胞衍生的外泌体 microRNAs 作为多发性硬化症治疗的新的潜在方法。
Cell Mol Neurobiol. 2024 May 7;44(1):44. doi: 10.1007/s10571-024-01478-1.
7
Hallmarks of sex bias in immuno-oncology: mechanisms and therapeutic implications.免疫肿瘤学中性别偏见的特征:机制和治疗意义。
Nat Rev Cancer. 2024 May;24(5):338-355. doi: 10.1038/s41568-024-00680-z. Epub 2024 Apr 8.
8
Exosome Content-Mediated Signaling Pathways in Multiple Sclerosis.外泌体内容介导的多发性硬化症信号通路。
Mol Neurobiol. 2024 Aug;61(8):5404-5417. doi: 10.1007/s12035-023-03862-2. Epub 2024 Jan 8.
9
MicroRNAs Associated with Disability Progression and Clinical Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate.与接受醋酸格拉替雷治疗的多发性硬化症患者残疾进展和临床活动相关的微小RNA
Biomedicines. 2023 Oct 12;11(10):2760. doi: 10.3390/biomedicines11102760.
10
Multiple Sclerosis: New Insights into Molecular Pathogenesis and Novel Platforms for Disease Treatment.多发性硬化症:分子发病机制的新见解和疾病治疗的新平台。
Curr Drug Res Rev. 2024;16(2):175-197. doi: 10.2174/2589977516666230915103730.